| Literature DB >> 32033059 |
Aknarin Pintatum1, Surat Laphookhieo1, Emilie Logie2, Wim Vanden Berghe2, Wisanu Maneerat1.
Abstract
The essential oils of the fresh rhizomes; flowers; and leaves of Zingiber kerrii Craib were investigated using different extraction techniques; including solid-phase microextraction (SPME), hydrodistillation (HD), and organic solvent (OS), and characterized by gas chromatography-mass spectrometry (GC-MS). A total of 37 SPME; 19 HD; and 36 OS compounds were identified from the rhizome extract of Z. kerrii; with the major components being α-pinene; β-pinene; and terpinen-4-ol; respectively. From the flower extract; 16 SPME; 2 HD; and 10 OS compounds were identified; (E)-caryophyllene was found as a major compound by these techniques. The leaf extract exhibited 20 SPME; 13 HD; and 14 OS compounds; with α-pinene; (E)-caryophyllene; and n-hexadecanoic acid being the major compounds; respectively. The rhizome extract showed tyrosinase inhibitory activity of 71.60% and a total phenolic content of 22.4 mg gallic acid/g. The IC50 values of the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) assays were 25.2 µg/mL and 153.6 µg/mL; respectively; and the ferric ion reducing antioxidant power (FRAP) assay value was 318.5 µM ascorbic acid equivalent (AAE)/g extract. The rhizome extract showed weak antibacterial activity. This extract showed no adverse toxicity in human keratinocyte (HaCaT) cell lines at concentrations below 200 µg/mL.Entities:
Keywords: Zingiber kerrii; anti-tyrosinase; biological activity; chemical composition; cytotoxicity
Year: 2020 PMID: 32033059 PMCID: PMC7072701 DOI: 10.3390/biom10020228
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Chemical compositions of fresh rhizomes, flowers, and leaves of Zingiber kerrii.
| Compound | LRI Cal. | LRI Lit. | Rhizomes (%) | Flowers (%) | Leaves (%) | Identification Methods | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SPME | HD | OS | SPME | HD | OS | SPME | HD | OS | ||||
| 931 | 930 | 0.5 ± 0.04 | nd | nd | nd | nd | nd | 0.3 ± 0.1 | nd | nd | MS, LRI, AD | |
| 939 | 939 | 22.1 ± 0.6 | 24.3 ± 1.6 | 3.2 ± 0.3 | 22.2 ± 1.8 | nd | nd | 39.7 ± 0.7 | 1.7 ± 0.1 | 3.0 ± 1.9 | MS, LRI, AD | |
| 953 | 952 | nd | nd | nd | 0.5 ± 0.2 | nd | nd | nd | nd | nd | MS, LRI, AD | |
| Camphene | 954 | 954 | 2.6 ± 0.4 | 1.5 ± 0.3 | 0.2 ± 0.04 | 0.4 ± 0.1 | nd | nd | nd | nd | nd | MS, LRI, AD |
| Sabinene | 979 | 975 | 12.3 ± 1.7 | nd | nd | 1.3 ± 0.7 | nd | nd | 1.6 ± 0.5 | nd | nd | MS, LRI, AD |
| 983 | 979 | 17.2 ± 0.7 | 33.1 ± 2.5 | 7.7 ± 1.1 | 8.6 ± 1.1 | nd | nd | 6.3 ± 0.5 | 1.8 ± 0.3 | 2.6 ± 0.9 | MS, LRI, AD | |
| 2,2,4,6,6-Pentamethyl heptane | 985 | - | nd | nd | nd | nd | nd | nd | nd | nd | 2.4 ± 1.4 | LRI, AD |
| Myrcene | 996 | 990 | 1.5 ± 0.5 | 2.0 ± 0.4 | 0.4 ± 0.1 | 0.9 ± 0.2 | nd | nd | 0.4 ± 0.1 | nd | nd | MS, LRI, AD |
| 3-( | 1002 | 1002 | nd | nd | nd | nd | nd | nd | nd | nd | 1.7 ± 1.1 | MS, LRI, AD |
| 1006 | 1002 | 0.5 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1010 | 1002 | 0.2 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1015 | 1011 | 0.7 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1021 | 1017 | 0.6 ± 0.1 | 0.8 ± 0.2 | 0.1 ± 0.05 | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1029 | 1026 | 2.7 ± 0.3 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| Limonene | 1033 | 1029 | nd | 4.0 ± 0.6 | 1.8 ± 0.2 | 1.7 ± 0.3 | nd | nd | 1.8 ± 0.2 | 1.4 ± 0.6 | 0.5 ± 0.3 | MS, LRI, AD |
| Sylvestrene | 1034 | 1030 | 3.0 ± 0.3 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| ( | 1041 | 1037 | 0.4 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| ( | 1051 | 1050 | 8.1 ± 0.3 | 7.8 ± 0.5 | 4.1 ± 0.8 | 1.7 ± 0.1 | nd | nd | 1.5 ± 0.5 | 1.2 ± 0.3 | nd | MS, LRI, AD |
| 1063 | 1059 | 1.7 ± 0.3 | nd | 0.7 ± 0.1 | 0.9 ± 0.1 | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1083 | 1088 | nd | 0.8 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1086 | 1089 | nd | nd | 1.8 ± 0.3 | nd | nd | 0.6 ± 0.1 | nd | nd | nd | MS, LRI, AD | |
| Terpinolene | 1094 | 1088 | 0.58 ± 0.18 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Linalool | 1106 | 1096 | nd | nd | 1.9 ± 0.2 | nd | nd | 1.1 ± 0.1 | nd | 4.0 ± 0.5 | 3.3 ± 0.4 | MS, LRI, AD |
| allo-Ocimene | 1133 | 1132 | 0.6 ± 0.2 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Borneol | 1170 | 1169 | nd | 0.8 ± 0.2 | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Terpinen-4-ol | 1182 | 1177 | 1.8 ± 0.6 | 3.8 ± 0.3 | 11.5 ± 0.6 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| 1196 | 1188 | nd | 0.8 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| Myrtenal | 1201 | 1195 | nd | nd | 2.3 ± 0.6 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Verbenone | 1213 | 1205 | nd | nd | 0.4 ± 0.1 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Piperitone | 1248 | 1252 | nd | nd | 0.2 ± 0.02 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Isobornyl acetate | 1289 | 1285 | 0.2 ± 0.1 | 0.5 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Indole | 1290 | 1291 | nd | nd | nd | nd | nd | 1.7 ± 0.9 | nd | nd | nd | MS, LRI, AD |
| Bornyl acetate | 1301 | 1288 | nd | nd | 0.6 ± 0.1 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| ( | 1303 | 1298 | nd | nd | 0.5 ± 0.2 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| 1340 | 1338 | 0.3 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1353 | 1348 | 5.3 ± 0.6 | nd | 0.6 ± 0.1 | nd | nd | nd | 0.1 ± 0.06 | nd | nd | MS, LRI, AD | |
| Cyclosativene | 1370 | 1371 | nd | 2.3 ± 0.4 | 2.8 ± 0.6 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| 1374 | 1375 | 3.9 ± 0.8 | nd | nd | 0.7 ± 0.1 | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1380 | 1376 | 0.2 ± 0.1 | 1.3 ± 0.3 | 2.0 ± 0.5 | nd | nd | nd | 3.2 ± 0.6 | nd | nd | MS, LRI, AD | |
| 1388 | 1388 | 0.89 ± 0.15 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1397 | 1390 | nd | 1.7 ± 0.3 | 3.0 ± 0.6 | 0.5 ± 0.1 | nd | nd | 3.8 ± 0.4 | 12.2 ± 1.3 | 3.6 ± 0.6 | MS, LRI, AD | |
| Longifolene | 1413 | 1407 | 3.6 ± 0.6 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| ( | 1424 | 1419 | nd | 4.2 ± 0.4 | 3.2 ± 0.3 | 58.1 ± 1.3 | 94.8 ± 0.9 | 74.2 ± 1.5 | 21.2 ± 0.8 | 24.2 ± 1.6 | 6.0 ± 0.8 | MS, LRI, AD |
| 1432 | 1432 | 0.6 ± 0.3 | nd | 0.2 ± 0.1 | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1437 | 1436 | 0.2 ± 0.1 | nd | 0.4 ± 0.1 | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1456 | 1454 | nd | nd | 0.6 ± 0.1 | 0.8 ± 0.3 | 2.3 ± 0.5 | 2.0 ± 0.03 | 0.4 ± 0.05 | 1.4 ± 0.7 | nd | MS, LRI, AD | |
| ( | 1460 | 1456 | nd | nd | nd | nd | nd | nd | 0.1 ± 0.05 | nd | nd | MS, LRI, AD |
| 9-epi-( | 1463 | 1466 | 0.5 ± 0.1 | nd | nd | nd | nd | nd | 0.5 ± 0.5 | nd | nd | MS, LRI, AD |
| ( | 1474 | 1476 | nd | 1.3 ± 0.7 | 3.0 ± 0.4 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| 1480 | 1479 | 0.8 ± 0.2 | nd | nd | nd | nd | nd | 0.2 ± 0.1 | nd | nd | MS, LRI, AD | |
| 1488 | 1480 | nd | nd | nd | nd | nd | nd | 3.5 ± 0.7 | 4.2 ± 0.4 | 2.9 ± 0.4 | MS, LRI, AD | |
| Germacrene D | 1484 | 1485 | 0.2 ± 0.1 | nd | nd | nd | nd | 0.4 ± 0.1 | nd | nd | nd | MS, LRI, AD |
| 1486 | 1492 | 0.2 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| ( | 1489 | 1493 | 0.3 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| 1501 | 1493 | nd | nd | 2.8 ± 0.3 | 0.2 ± 0.1 | nd | nd | 4.4 ± 0.7 | 11.7 ± 1.0 | 3.8 ± 0.5 | MS, LRI, AD | |
| Valencene | 1496 | 1496 | 0.3 ± 0.1 | nd | nd | nd | nd | nd | nd | 21.2 ± 1.3 | nd | MS, LRI, AD |
| Isodaucene | 1497 | 1500 | nd | 4.1 ± 0.4 | 2.7 ± 0.4 | nd | nd | nd | nd | nd | 4.2 ± 1.0 | MS, LRI, AD |
| 1504 | 1500 | 0.6 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1514 | 1505 | nd | nd | nd | 0.5 ± 0.1 | nd | nd | 2.7 ± 0.6 | nd | nd | MS, LRI, AD | |
| 7-epi- | 1520 | 1522 | 0.6 ± 0.1 | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| 1527 | 1522 | nd | nd | nd | nd | nd | nd | 3.2 ± 0.5 | 4.8 ± 0.3 | 1.6 ± 0.6 | MS, LRI, AD | |
| 1529 | 1523 | 0.2 ± 0.1 | nd | 1.5 ± 0.4 | 0.3 ± 0.1 | nd | 0.4 ± 0.1 | nd | nd | nd | MS, LRI, AD | |
| ( | 1535 | 1531 | nd | nd | nd | nd | nd | nd | 0.63 ± 0.76 | nd | nd | MS, LRI, AD |
| Germacrene B | 1559 | 1561 | nd | 1.9 ± 0.9 | 4.2 ± 0.6 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| ( | 1568 | 1563 | 0.2 ± 0.1 | nd | 1.8 ± 0.6 | nd | nd | nd | nd | 1.9 ± 0.8 | nd | MS, LRI, AD |
| Caryophyllene oxide | 1586 | 1583 | nd | nd | 4.4 ± 0.7 | nd | nd | 0.8 ± 0.1 | nd | nd | 1.9 ± 1.3 | MS, LRI, AD |
| 1627 | 1632 | nd | nd | 2.1 ± 0.5 | nd | nd | nd | nd | nd | nd | MS, LRI, AD | |
| 1648 | - | nd | nd | 4.1 ± 0.4 | nd | nd | nd | nd | nd | nd | LRI, AD | |
| Cryptomeridiol | 1809 | 1813 | nd | nd | 5.0 ± 0.7 | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Cyclohexadecanolide | 1936 | 1933 | nd | nd | nd | nd | nd | nd | nd | nd | nd | MS, LRI, AD |
| Sandaracopimaradiene | 1948 | - | nd | nd | 0.2 ± 0.1 | nd | nd | nd | nd | nd | nd | LRI, AD |
| 1960 | 1959 | nd | nd | 8.7 ± 0.9 | nd | nd | 14.9 ± 0.4 | nd | nd | 55.7 ± 1.3 | MS, LRI, AD | |
| Number of constituents | 37 | 19 | 36 | 16 | 2 | 9 | 20 | 13 | 14 | |||
| % of constituents identified | 95.5% | 96.9% | 90.8% | 99.1% | 97.2% | 97.1% | 95.4% | 91.8% | 93.1% | |||
| Yield ( | 0.4% | 0.6% | 0.2% | 0.3% | 0.2% | 0.3% | ||||||
| Monoterpene hydrocarbons | 75.0% | 74.3% | 20.1% | 38.0% | - | 0.6% | 51.5% | 6.2% | - | |||
| Oxygenated monoterpenes | 2.0% | 5.9% | 17.6% | - | - | 1.1% | - | 4.0% | 3.3% | |||
| Sesquiterpene hydrocarbons | 18.4% | 16.7% | 26.9% | 61.1% | 97.2% | 77.0% | 43.9% | 79.7% | 22.1% | |||
| Oxygenated sesquiterpenes | 0.2% | - | 17.3% | - | - | 1.7% | - | 1.9% | 1.9% | |||
| Diterpene hydrocarbons | - | - | 0.2% | - | - | - | - | - | - | |||
| Fatty acid esters | - | - | 8.7% | - | - | 14.9% | - | - | 55.7% | |||
| Other compounds | - | - | - | - | - | 1.7% | - | - | - | |||
Note: LRI Lit.: retention indices from literature by Adams [37]; LRI Cal.: experimentally determined; MS: identification by mass spectral database match with National Institute of Standards and Technology (NIST) and Wiley; LRI: linear retention index using the HP-5ms column (experimentally determined using the C8–C20 n-alkanes standard); AD: Adams database match [37]; nd: not detected; HD: hydrodistillation; OS: organic solvent; SPEM: solid-phase microextraction. Values are mean ± standard deviation (SD), n = 3.
Figure 1Principal component analysis (PCA) plots of all plant parts and extraction techniques.
Figure 2PCA loading plots revealing the compounds present in Z. kerrii.
Total phenolic content, antioxidant activity, and tyrosinase inhibitory activity of Z. kerrii rhizome extract.
| Sample | Total Phenolic Content (mg GAE/100 g Extract) | Antioxidant (IC50, μg/mL) | FRAP (mM AAE/g Extract) | Tyrosinase Inhibitory Activity (mg KAE/g Extract) | |
|---|---|---|---|---|---|
| DPPH | ABTS | ||||
|
| 2.2 ± 0.1 | 143.6 ± 2.3 | 169.7 ± 41.0 | 0.3 ± 0.01 | 22.7 ± 0.8 |
| Ascorbic acid | - | 1.6 ± 0.8 | 5.2 ± 0.8 | - | - |
Note: GAE: gallic acid equivalence; AAE: ascorbic acid equivalence; KAE: kojic acid equivalence; DPPH: 2,2-diphenyl-1-picrylhydrazyl; ABTS: 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt; FRAP: ferric ion reducing antioxidant power. Values are the mean ± SD, n = 3.
Cytotoxicity of Z. kerrii rhizome extract on HaCaT cells after 24 h treatment.
| Concentration (µg/mL) | % Cell Viability |
|---|---|
| 12.5 | 98.7 ± 6.0 |
| 25 | 95.9 ± 6.9 |
| s50 | 99.9 ± 0.3 |
| 100 | 97.5 ± 16.0 |
| 200 | 23.1 ± 10.4 |
Note: values are the mean ± SD, n = 3.
Antibacterial activity of Z. kerrii rhizome extract.
| Sample | Gram (+) Bacteria | Gram (−) Bacteria | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| 1280 | 1280 | 640 | 1280 | - | 640 | 1280 | - |
| Vancomycin | 320 | 160 | 10 | 1280 | - | - | - | - |
| Gentamycin | - | - | - | - | 160 | 80 | 640 | 160 |
| Ampicillin | - | 320 | 5 | 320 | 80 | 640 | 1280 | 160 |
| DMSO | 1280 | 1280 | - | 1280 | 1280 | - | 1280 | - |